RD
Robert Driscoll Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
16.7%
Negative
8.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Reiterated
| $10 |
89%
upside
| 1 | -8.5% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $36 |
139%
upside
| 1 | +6.8% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $21.50 |
0%
upside
| 2 | +76% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $36 |
272%
upside
| 1 | +19% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $19 |
29%
downside
| 1 | +6.2% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Underperform
Initiated
| $7 |
41%
downside
| 1 | +20% |
0
%
| 26 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $11 |
0%
upside
| 1 | – |
–
| 25 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $52 |
53%
upside
| 1 | +13% |
0
%
| 18 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $53 |
49%
upside
| 2 | +30% |
0
%
| 13 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $7 |
600%
upside
| 1 | +18% |
0
%
| 10 Feb ‘26 2 months ago |
|
|
|
Outperform
Maintained
| $19 |
776%
upside
| 1 | +31% |
0
%
| 4 Feb ‘26 2 months ago |
|